Inhibition of adenosine cyclic 3', 5'-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine, and related compounds.
D000241:Adenosine / Q000494:pharmacology*; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D000619:Aminohydrolases / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000037:antagonists & inhibitors*; D004176:Dipyridamole / Q000494:pharmacology; D005260:Female; D003012:Microbial Collagenase / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011691:Puromycin / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014970:Xanthines / Q000494:pharmacology
D000067956:Adenylyl Cyclase Inhibitors; D010726:Phosphodiesterase Inhibitors; D014970:Xanthines; D000249:Adenosine Monophosphate; D011691:Puromycin; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D003012:Microbial Collagenase; D000619:Aminohydrolases; D000241:Adenosine; D009638:Norepinephrine